Abstract
Objectives
The study aimed to evaluate dual liquid chromatography (LC) coupled to high-resolution mass spectrometry (HRMS) for the simultaneous analysis of small and large molecule drugs by development and application of a validated bioanalytical method.
Methods
The oral antihyperglycemic drugs (OAD) dapagliflozin, empagliflozin, glibenclamide, glimepiride, metformin, pioglitazone, repaglinide, saxagliptin, sitagliptin, and vildagliptin, as well as the antihyperglycemic peptides exenatide, human insulin, insulin aspart, insulin degludec, insulin detemir, insulin glargine, insulin glulisine, insulin lispro, and semaglutide were included in the analytical procedure. Analytes were extracted using a combination of protein precipitation and solid-phase extraction. Two identical reversed-phase columns were used for separation followed by Orbitrap high-resolution mass spectrometry. The whole procedure was validated according to international recommendations.
Results
Different MS parameters had to be used for the two analyte groups, but dual LC separation allowed elution of all analytes within 12 min using the same column type. The analytical procedure was accurate and precise for most of the compounds except for exenatide, semaglutide, and insulin glargine, which were included qualitatively in the method. Analysis of proof-of-concept samples revealed OAD concentrations mostly within their therapeutic range, insulins could be detected in five cases but at concentrations below the lower limit of quantification except for one case.
Conclusions
Dual LC in combination with HRMS was shown to be a suitable platform to analyze small and large molecules in parallel and the current method allowed the determination of a total of 19 antihyperglycemic drugs in blood plasma within 12 min.
Acknowledgments
The authors like to thank Cathy M. Jacobs, Fabian Frankenfeld, Juel Maalouli Shaar, Sascha K. Manier, Matthias J. Richter, Gabriele Ulrich, Claudio De Nardi, Yvonne Song, PD Dr. Andreas Thomas, Dr. Christoph Sauer, and Synlab Deutschland for their support and/or helpful discussion.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
References
1. Remane, D, Wissenbach, DK, Peters, FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology – an update. Clin Biochem 2016;49:1051–71. https://doi.org/10.1016/j.clinbiochem.2016.07.010.Search in Google Scholar PubMed
2. Novakova, L. Challenges in the development of bioanalytical liquid chromatography-mass spectrometry method with emphasis on fast analysis. J Chromatogr A 2013;1292:25–37. https://doi.org/10.1016/j.chroma.2012.08.087.Search in Google Scholar PubMed
3. Maurer, HH, Meyer, MR. High-resolution mass spectrometry in toxicology: current status and future perspectives. Arch Toxicol 2016;90:2161–72. https://doi.org/10.1007/s00204-016-1764-1.Search in Google Scholar PubMed
4. Jacobs, CM, Wagmann, L, Meyer, MR. Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics. Anal Bioanal Chem 2021;413:1729–37. https://doi.org/10.1007/s00216-020-03143-0.Search in Google Scholar PubMed PubMed Central
5. Remane, D, Meyer, MR, Wissenbach, DK, Maurer, HH. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Anal Bioanal Chem 2011;401:1341–52. https://doi.org/10.1007/s00216-011-5187-9.Search in Google Scholar PubMed
6. Thomas, A, Thevis, M. Recent advances in the determination of insulins from biological fluids. Adv Clin Chem 2019;93:115–67. https://doi.org/10.1016/bs.acc.2019.07.003.Search in Google Scholar PubMed
7. Blackburn, M. Advances in the quantitation of therapeutic insulin analogues by LC-MS/MS. Bioanalysis 2013;5:2933–46. https://doi.org/10.4155/bio.13.257.Search in Google Scholar PubMed
8. Chambers, EE, Fountain, KJ, Smith, N, Ashraf, L, Karalliedde, J, Cowan, D, et al.. Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma. Anal Chem 2014;86:694–702. https://doi.org/10.1021/ac403055d.Search in Google Scholar PubMed
9. Nguyen, HP, Schug, KA. The advantages of ESI-MS detection in conjunction with HILIC mode separations: fundamentals and applications. J Separ Sci 2008;31:1465–80. https://doi.org/10.1002/jssc.200700630.Search in Google Scholar PubMed
10. EMA. Guideline on bioanalytical method validation. London, UK: European Medicines Agency; 2011.Search in Google Scholar
11. Thomas, A, Yang, R, Petring, S, Bally, L, Thevis, M. Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS. Drug Test Anal 2020;12:382–90. https://doi.org/10.1002/dta.2765.Search in Google Scholar PubMed
12. Matuszewski, BK, Constanzer, ML, Chavez-Eng, CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75:3019–30. https://doi.org/10.1021/ac020361s.Search in Google Scholar PubMed
13. Foulon, N, Goonatilleke, E, MacCoss, MJ, Emrick, MA, Hoofnagle, AN. Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies. J Mass Spectrom Adv Clin Lab 2022;25:19–26. https://doi.org/10.1016/j.jmsacl.2022.06.003.Search in Google Scholar PubMed PubMed Central
14. Maurer, HH, Kratzsch, C, Kraemer, T, Peters, FT, Weber, AA. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2002;773:63–73. https://doi.org/10.1016/s1570-0232(01)00618-3.Search in Google Scholar PubMed
15. Lam, YH, Leung, MT, Ching, CK, Mak, TWL. Simultaneous detection of 24 oral antidiabetic drugs and their metabolites in urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2020;1141:122020. https://doi.org/10.1016/j.jchromb.2020.122020.Search in Google Scholar PubMed
16. Murphy, EL, Joy, AP, Ouellette, RJ, Barnett, DA. Improved intact peptide and protein quantitation by LC‐MS: battling the deleterious effects of analyte adsorption. Anal Sci Adv2020;2:299–307. https://doi.org/10.1002/ansa.202000102.Search in Google Scholar
17. Ewles, M, Goodwin, L. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS. Bioanalysis 2011;3:1379–97. https://doi.org/10.4155/bio.11.112.Search in Google Scholar PubMed
18. Thomas, A, Schanzer, W, Thevis, M. Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS). Drug Test Anal 2014;6:1125–32. https://doi.org/10.1002/dta.1710.Search in Google Scholar PubMed
19. Hess, C, Thomas, A, Thevis, M, Stratmann, B, Quester, W, Tschoepe, D, et al.. Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal Bioanal Chem 2012;404:1813–22. https://doi.org/10.1007/s00216-012-6271-5.Search in Google Scholar PubMed
20. Lucidi, P, Porcellati, F, Candeloro, P, Cioli, P, Marinelli Andreoli, A, Marzotti, S, et al.. Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response study. Nutr Metabol Cardiovasc Dis 2014;24:709–16. https://doi.org/10.1016/j.numecd.2014.02.008.Search in Google Scholar PubMed
21. Cai, J, Yan, Z. Re-examining the impact of minimal scans in liquid chromatography-mass spectrometry analysis. J Am Soc Mass Spectrom 2021;32:2110–22. https://doi.org/10.1021/jasms.1c00073.Search in Google Scholar PubMed
22. van der Aart-van der Beek, AB, Wessels, AMA, Heerspink, HJ, Touw, DJ. Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasma and urine. J Chromatogr B Anal Technol Biomed Life Sci 2020;1152:122257. https://doi.org/10.1016/j.jchromb.2020.122257.Search in Google Scholar PubMed
23. Shah, PA, Shrivastav, PS, Shah, JV, George, A. Simultaneous quantitation of metformin and dapagliflozin in human plasma by LC-MS/MS: application to a pharmacokinetic study. Biomed Chromatogr 2019;33:e4453. https://doi.org/10.1002/bmc.4453.Search in Google Scholar PubMed
24. Mabrouk, MM, Soliman, SM, El-Agizy, HM, Mansour, FR. A UPLC/DAD method for simultaneous determination of empagliflozin and three related substances in spiked human plasma. BMC Chem 2019;13:83. https://doi.org/10.1186/s13065-019-0604-9.Search in Google Scholar PubMed PubMed Central
25. Al Bratty, M, Alhazmi, HA, Javed, SA, Lalitha, KG, Asmari, M, Wolker, J, et al.. Development and validation of LC–MS/MS method for simultaneous determination of metformin and four gliptins in human plasma. Chromatographia 2017;80:891–9. https://doi.org/10.1007/s10337-017-3288-0.Search in Google Scholar
26. Abdelwaly, EA, Mohamed, AA, El‐Kosasy, AM, Ayad, MF. Simultaneous quantitative determination of insulin aspart and insulin degludec in human plasma using simple shoot LC method. Biomed Chromatogr 2022;36:e5292. https://doi.org/10.1002/bmc.5292.Search in Google Scholar PubMed
27. Zhai, J, Li, L, Dong, L, Dong, K, Xiang, S, Gui, L, et al.. Simultaneous quantitative determination of liraglutide and insulin degludec in rat plasma by liquid chromatography-tandem mass spectrometry method and its application. Biomed Chromatogr 2020;34:e4921. https://doi.org/10.1002/bmc.4921.Search in Google Scholar PubMed
28. Schulz, M, Schmoldt, A, Andresen-Streichert, H, Iwersen-Bergmann, S. Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care 2020;24:195. https://doi.org/10.1186/s13054-020-02915-5.Search in Google Scholar PubMed PubMed Central
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/cclm-2022-1316).
© 2023 Walter de Gruyter GmbH, Berlin/Boston
